Order Total (1 Item Items):
Shipping Destination:
Chau Cindy (54 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (54)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (43)
- As New, Fine or Near Fine (8)
- Very Good or Good (3)
- Fair or Poor (No further results match this refinement)
- As Described (No further results match this refinement)
Binding
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (15)
- Not Print on Demand (33)
Language (2)
Free Shipping
Seller Location
Seller Rating
-
Condition: As New. Unread book in perfect condition.
-
Condition: As New. Unread book in perfect condition.
-
-
-
paperback. Condition: Good.
-
Hardback. Condition: Very Good. xvii + 428 pp. Rubber-stamped on front free endpaper. book.
-
Early Bilingual Explorers: Mid-Autumn Festival ??????????? (Early Bilingual Explorers ???????)
Book 1 of 2: Early Bilingual Explorers ???????Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 10.43
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Mid-Autumn Festival ??? (Early Bilingual Explorers ???????)
Book 2 of 2: Early Bilingual Explorers ???????Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 10.43
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
-
PF. Condition: New.
-
Early Bilingual Explorers: Mid-Autumn Festival ???????????
Book 1 of 2: Early Bilingual Explorers ???????Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
Condition: New.
-
Mid-Autumn Festival ???
Book 2 of 2: Early Bilingual Explorers ???????Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
Condition: New.
-
Early Bilingual Explorers: Mid-Autumn Festival ???????????
Book 1 of 2: Early Bilingual Explorers ???????Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
Condition: As New. Unread book in perfect condition.
-
Mid-Autumn Festival ???
Book 2 of 2: Early Bilingual Explorers ???????Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
Condition: As New. Unread book in perfect condition.
-
Drug Management of Prostate Cancer
Seller: Phatpocket Limited, Waltham Abbey, HERTS, United Kingdom
Seller rating 5 out of 5 stars
Condition: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
-
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
-
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
-
Mid-Autumn Festival and#20013;and#31179;and#33410;
Book 2 of 2: Early Bilingual Explorers ???????Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 5 out of 5 stars
£ 11.67
£ 3.29 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketPAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
-
Early Bilingual Explorers
Book 1 of 2: Early Bilingual Explorers ???????Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 5 out of 5 stars
£ 11.67
£ 3.29 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketPAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
-
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
-
Taschenbuch. Condition: Neu. Neuware.
-
Paperback. Condition: New. In shrink wrap. Looks like an interesting title!
-
Condition: Sehr gut. Zustand: Sehr gut | Seiten: 448 | Sprache: Englisch | Produktart: Bücher | Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodgesż report of the dra- therapeutic intervention. These include drugs that are matic clinical effects of suppressing serum testos- more active or less toxic chemotherapy agents; drugs terone levels in men with advanced prostate cancer that induce androgen deprivation; drugs that target in 1941, hormone therapy (also called androgen the androgen receptor and/or androgen synthesis; deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer. ADT combined antagonists and matrix metalloproteinase inhibitors; with radiation therapy is a standard of care in the and immunologic approaches. Many of these agents treatment of men with locally advanced prostate seem promising and the rationale and effcacy of cancer on the basis of evidence that shows improved these emerging therapies remain to be validated in survival. The role of ADT in the management of future clinical trials.
-
Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development)
Book 80 of 96: Cancer Drug Discovery and DevelopmentSeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 230
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development)
Book 80 of 96: Cancer Drug Discovery and DevelopmentSeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 230
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Drug Management of Prostate Cancer
Language: English
Published by Springer New York, Copernicus, 2010
ISBN 10: 1603278311 ISBN 13: 9781603278317
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodges' report of the dra- therapeutic intervention. These include drugs that are matic clinical effects of suppressing serum testos- more active or less toxic chemotherapy agents; drugs terone levels in men with advanced prostate cancer that induce androgen deprivation; drugs that target in 1941, hormone therapy (also called androgen the androgen receptor and/or androgen synthesis; deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer. ADT combined antagonists and matrix metalloproteinase inhibitors; with radiation therapy is a standard of care in the and immunologic approaches. Many of these agents treatment of men with locally advanced prostate seem promising and the rationale and effcacy of cancer on the basis of evidence that shows improved these emerging therapies remain to be validated in survival. The role of ADT in the management of future clinical trials.
-
Condition: New. pp. 698 1st Edition.
-
Taschenbuch. Condition: Neu. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics | Michelle A. Rudek (u. a.) | Taschenbuch | Cancer Drug Discovery and Development | ix | Englisch | 2016 | Springer | EAN 9781493938988 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development)
Book 80 of 96: Cancer Drug Discovery and DevelopmentSeller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Seller rating 5 out of 5 stars
Condition: New. This book offers a detailed, step-by-step guide to the successful design and approval of anticancer drugs. It covers all steps, from the identification of cancer-specific molecular targets to clinical trial design and all the phases of clinical trials. Editor(s): Rudek, Michelle A.; Chau, Cindy H.; Figg, William D.; McLeod, Howard L. Series: Cancer Drug Discovery and Development. Num Pages: 845 pages, 99 black & white illustrations, 46 colour illustrations. BIC Classification: MQP. Category: (P) Professional & Vocational. Dimension: 185 x 258 x 37. Weight in Grams: 1620. . 2014. Second Edition 2014. hardcover. . . . .
-
Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
Book 80 of 96: Cancer Drug Discovery and DevelopmentLanguage: English
Published by Springer New York, Springer New York, 2014
ISBN 10: 1461491347 ISBN 13: 9781461491347
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - There are many steps on the road from discovery of an anticancer drug to securing its final approval by the Food and Drug Administration. In this thoroughly updated and expanded second edition of the Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, leading investigators synthesize an invaluable overview of the experimental and clinical processes of anticancer drug development, creating a single indispensable reference that covers all the steps from the identification of cancer-specific molecular targets to screening techniques and the development and validation of bioanalytical methods to clinical trial design and all phases of clinical trials. The authors have included new material on phase 0 trials in oncology, organ dysfunction trials, drug formulations and their impact on anticancer drug PK/PD including strategies to improve drug delivery, pharmacogenomics and cancer therapy, high throughput platforms in drug metabolism and transport pharmacogenetics, imaging in drug development and nanotechnology in cancer.Authoritative and up-to-date, Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, 2nd Edition provides in one comprehensive and highly practical volume a detailed step-by-step guide to the successful design and approval of anticancer drugs.Road map to anticancer drug development from discovery to NDA submissionDiscussion of molecular targets and preclinical screeningDevelopment and validation of bioanalytical methodsChapters on clinical trial design and phase 0, I, II, III clinical trialsPharmacokinetics, pharmacodynamics, pharmacogenomics, and pharmacogenetics of anticancer agentsReview of the drug development process from both laboratory and clinical perspectivesNew technological advances in imaging, high throughput platforms, and nanotechnology in anticancer drug development.
